Physicians Formula Holdings anticipates 7-10% sales increase
Colour cosmetics expected to drive sales growth in 2012
It is believed earnings per share will fall between $0.07 and $0.15 for 2012, up from an expected $0.04 to $0.14 loss per share for 2011.
“We are excited by our prospects for 2012. Our investment strategy in 2011 has clearly paid dividends as we were the fastest growing colour cosmetic brand among the top eight brands at point of sale over the last 52 weeks, according to AC Nielsen,” commented Ingrid Jackel, chairwoman and ceo. “In 2012, we intend to reap the benefits of those investments, expanding the productivity of our colour cosmetics business and the distribution of our new skin care platform. As a result we expect to generate strong growth in net sales in 2012 and to return the company to profitability.”
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Regulatory
It’s complicated: Estée Lauder Companies and Puig’s relationship status if they enter this merger
The news that Estée Lauder Companies is in ‘discussions’ with Puig around a potential merger has shaken the beauty industry, but could this mega deal be mutually beneficial, or will it dilute what makes both organisations unique? CB investigates
Recruitment
Ex-Unilever Prestige CEO Vasiliki Petrou partners with Semcap on beauty and wellness vertical
Petrou and firm Semcap look to invest in clinically backed skin care, cosmetics, fragrances and hair care, as well as personalised health solutions and technologies, via a new beauty and wellness vertical